{"id":824033,"date":"2022-09-30T19:01:15","date_gmt":"2022-09-30T17:01:15","guid":{"rendered":"https:\/\/15.161.165.86\/non-categorizzato\/navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders\/"},"modified":"2022-09-30T19:01:15","modified_gmt":"2022-09-30T17:01:15","slug":"navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders\/","title":{"rendered":"Navidea Biopharmaceuticals Appoints Joshua Wilson to the Board of Directors; Announces Dates Related to its 2022 Annual Meeting of Stockholders"},"content":{"rendered":"DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (\u201cNavidea\u201d or the \u201cCompany\u201d), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced the appointment of Joshua (\u201cJosh\u201d) Wilson to its Board of Directors, effective September 30, 2022, with a term ending concurrently with the Company\u2019s 2024 annual stockholders\u2019 meeting.\n\n\n\nMr. Wilson is a seasoned banking and finance executive with more than 23 years of financial services and family office experience. During his career, Mr. Wilson focused his efforts on raising capital and streamlining company operations for profit and non-profit entities, raising more than $500 million. Currently, M
Abbonati<\/a> o Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"

DUBLIN, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (\u201cNavidea\u201d or the \u201cCompany\u201d), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced the appointment of Joshua (\u201cJosh\u201d) Wilson to its Board of Directors, effective September 30, 2022, with a term ending concurrently with the Company\u2019s 2024 annual stockholders\u2019 meeting. Mr. Wilson […]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49625],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-824033","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-north-america"],"acf":[],"yoast_head":"\nNavidea Biopharmaceuticals Appoints Joshua Wilson to the Board of Directors; Announces Dates Related to its 2022 Annual Meeting of Stockholders - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Navidea Biopharmaceuticals Appoints Joshua Wilson to the Board of Directors; Announces Dates Related to its 2022 Annual Meeting of Stockholders - BeBeez\" \/>\n<meta property=\"og:description\" content=\"DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (\u201cNavidea\u201d or the \u201cCompany\u201d), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced the appointment of Joshua (\u201cJosh\u201d) Wilson to its Board of Directors, effective September 30, 2022, with a term ending concurrently with the Company\u2019s 2024 annual stockholders\u2019 meeting. Mr. Wilson […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-30T17:01:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Navidea Biopharmaceuticals Appoints Joshua Wilson to the Board of Directors; Announces Dates Related to its 2022 Annual Meeting of Stockholders\",\"datePublished\":\"2022-09-30T17:01:15+00:00\",\"dateModified\":\"2022-09-30T17:01:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders\/\"},\"wordCount\":1330,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in North America\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders\/\",\"name\":\"Navidea Biopharmaceuticals Appoints Joshua Wilson to the Board of Directors; Announces Dates Related to its 2022 Annual Meeting of Stockholders - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2022-09-30T17:01:15+00:00\",\"dateModified\":\"2022-09-30T17:01:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Navidea Biopharmaceuticals Appoints Joshua Wilson to the Board of Directors; Announces Dates Related to its 2022 Annual Meeting of Stockholders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Navidea Biopharmaceuticals Appoints Joshua Wilson to the Board of Directors; Announces Dates Related to its 2022 Annual Meeting of Stockholders - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders\/","og_locale":"en_US","og_type":"article","og_title":"Navidea Biopharmaceuticals Appoints Joshua Wilson to the Board of Directors; Announces Dates Related to its 2022 Annual Meeting of Stockholders - BeBeez","og_description":"DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (\u201cNavidea\u201d or the \u201cCompany\u201d), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced the appointment of Joshua (\u201cJosh\u201d) Wilson to its Board of Directors, effective September 30, 2022, with a term ending concurrently with the Company\u2019s 2024 annual stockholders\u2019 meeting. Mr. Wilson […]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders\/","og_site_name":"BeBeez","article_published_time":"2022-09-30T17:01:15+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders\/"},"author":{"name":"","@id":""},"headline":"Navidea Biopharmaceuticals Appoints Joshua Wilson to the Board of Directors; Announces Dates Related to its 2022 Annual Meeting of Stockholders","datePublished":"2022-09-30T17:01:15+00:00","dateModified":"2022-09-30T17:01:15+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders\/"},"wordCount":1330,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in North America"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders\/","name":"Navidea Biopharmaceuticals Appoints Joshua Wilson to the Board of Directors; Announces Dates Related to its 2022 Annual Meeting of Stockholders - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2022-09-30T17:01:15+00:00","dateModified":"2022-09-30T17:01:15+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-north-america\/navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/navidea-biopharmaceuticals-appoints-joshua-wilson-to-the-board-of-directors-announces-dates-related-to-its-2022-annual-meeting-of-stockholders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"Navidea Biopharmaceuticals Appoints Joshua Wilson to the Board of Directors; Announces Dates Related to its 2022 Annual Meeting of Stockholders"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/824033","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=824033"}],"version-history":[{"count":0,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/824033\/revisions"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=824033"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=824033"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=824033"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=824033"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=824033"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}